“A Real-world View of Ureteroscope Reprocessing Effectiveness…”
Event Navigation
Boston Scientific & OR Manager present*…”A real-world view of ureteroscope reprocessing effectiveness and what has happened since the FDA warning letter in April 2021″
In today’s challenging surgical reprocessing environment, your teams have questions and concerns. Join us for a discussion on “A real world view of ureteroscope reprocessing effectiveness and what has happened since the FDA warning letter in April 2021” where we’ll discuss recent findings on ureteroscope reprocessing effectiveness and provide solutions to improve your reprocessing outcomes.
A global Infection Prevention thought leader will share her insights on why there continues to be infection outbreaks and injuries with reusable ureteroscopes and how that affects facility operations and patient safety.
Learning Objectives
- Explain what recent research on ureteroscope reprocessing effectiveness has uncovered
- Describe the steps involved in effectively reprocessing flexible ureteroscopes and ensuring that they are truly “patient ready”
- Identify at least three red flags – indicating potential safety issues with reusable ureteroscopes
- Discuss strategies for reducing the risk of outbreaks associated with contaminated reusable ureteroscopes
Presenters: Cori Ofstead | CEO | Ofstead & Associates, Inc. & Carrie Shapiro, CMP | Senior Conference Manager | OR Manager Conference and OR Business Management Conference
Target Audience: OR Managers, OR Directors, Practice Managers or Physicians
It does not appear that CE credit is associated with this session.
Questions should be directed to: David Brumbach at DBrumbach@accessintel.com
* NOTE: This is a supplier and industry resource-sponsored webinar. HealthTrust has not approved and/or endorsed the content. This program may contain the mention of products, services, drugs or brands presented in a case study or comparative format. Such examples are intended for educational and informational purposes and should not be perceived as a HealthTrust endorsement of any particular supplier, product, service, drug, brand or approach.
